ID   Kasumi-5
AC   CVCL_6864
DR   Cosmic; 981580
DR   GEO; GSM4254133
DR   JCRB; JCRB1398
DR   Wikidata; Q54899522
RX   PubMed=32180206;
CC   Population: Chinese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8068; NUP98 + HGNC; HGNC:9859; RAP1GDS1; Name(s)=NUP98-RAP1GDS1 (PubMed=32180206).
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): JCRB=JCRB1398
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 10,11
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
RX   PubMed=32180206; DOI=10.1007/s13577-020-00347-5; PMCID=PMC7324421;
RA   Kasai F., Asou H., Ozawa M., Kobayashi K., Kuramitsu H., Satoh M.,
RA   Kohara A., Kaneko Y., Kawamura M.;
RT   "Kasumi leukemia cell lines: characterization of tumor genomes with
RT   ethnic origin and scales of genomic alterations.";
RL   Hum. Cell 33:868-876(2020).
//